Antisense approaches for the treatment of cancer

Cancer Invest. 2000;18(7):635-50. doi: 10.3109/07357900009032830.
No abstract available

Publication types

  • Review

MeSH terms

  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Genes, bcl-2 / physiology
  • Genes, myb / physiology
  • Genes, ras / physiology
  • Humans
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Oligodeoxyribonucleotides, Antisense / therapeutic use
  • Oligonucleotides, Antisense / therapeutic use*
  • Protein Kinase C / antagonists & inhibitors
  • Proto-Oncogene Proteins c-raf / antagonists & inhibitors
  • RNA, Messenger / analysis
  • Thionucleotides / therapeutic use

Substances

  • Oligodeoxyribonucleotides, Antisense
  • Oligonucleotides, Antisense
  • RNA, Messenger
  • Thionucleotides
  • ISIS 3521
  • ISIS 5132
  • Proto-Oncogene Proteins c-raf
  • Cyclic AMP-Dependent Protein Kinases
  • Protein Kinase C